Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Xingxing Li, Ling Wang, Jingjing Liu, Enyue Fang, Xiaohui Liu, Qinhua Peng, Zelun Zhang, Miao Li, Xinyu Liu, Xiaohong Wu, Danhua Zhao, Lihong Yang, Jia Li, Shouchun Cao, Yanqiu Huang, Leitai Shi, Hongshan Xu, Yunpeng Wang, Yue Suo, Guangzhi Yue, Jianhui Nie, Weijin Huang, Wenjuan Li & Yuhua Li. (2022) Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice. Emerging Microbes & Infections 11:1, pages 1890-1899.
Read now
Read now
Anis Askarizadeh, Ali Badiee & Ali Khamesipour. (2020) Development of nano-carriers for Leishmania vaccine delivery. Expert Opinion on Drug Delivery 17:2, pages 167-187.
Read now
Read now
Cecilia Trucchi, Chiara Paganino, Daniela Amicizia, Andrea Orsi, Valentino Tisa, Maria Francesca Piazza, Giancarlo Icardi & Filippo Ansaldi. (2019) Universal influenza virus vaccines: what needs to happen next?. Expert Opinion on Biological Therapy 19:7, pages 671-683.
Read now
Read now
Peggy Riese, Priya Sakthivel, Stephanie Trittel & Carlos A Guzmán. (2014) Intranasal formulations: promising strategy to deliver vaccines. Expert Opinion on Drug Delivery 11:10, pages 1619-1634.
Read now
Read now
Yoshikazu Yuki, Tomonori Nochi, Il Gyu Kong, Haruko Takahashi, Shin-ichi Sawada, Kazunari Akiyoshi & Hiroshi Kiyono. (2013) Nanogel-based antigen-delivery system for nasal vaccines. Biotechnology and Genetic Engineering Reviews 29:1, pages 61-72.
Read now
Read now
Michael Schotsaert, Xavier Saelens & Geert Leroux-Roels. (2012) Influenza vaccines: T-cell responses deserve more attention. Expert Review of Vaccines 11:8, pages 949-962.
Read now
Read now
Fabian Blank, Philip Stumbles & Christophe von Garnier. (2011) Opportunities and challenges of the pulmonary route for vaccination. Expert Opinion on Drug Delivery 8:5, pages 547-563.
Read now
Read now
Barbara C. Baudner & Derek T. O’Hagan. (2010) Bioadhesive delivery systems for mucosal vaccine delivery. Journal of Drug Targeting 18:10, pages 752-770.
Read now
Read now
Selma Calcagnile & Gian Vincenzo Zuccotti. (2010) The virosomal adjuvanted influenza vaccine. Expert Opinion on Biological Therapy 10:2, pages 191-200.
Read now
Read now
Michael Schotsaert, Marina De Filette, Walter Fiers & Xavier Saelens. (2009) Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Review of Vaccines 8:4, pages 499-508.
Read now
Read now
Ali M Harandi, Gwyn Davies & Ole F Olesen. (2009) Vaccine adjuvants: scientific challenges and strategic initiatives. Expert Review of Vaccines 8:3, pages 293-298.
Read now
Read now
Hansi J Dean. (2006) Alternative routes of influenza vaccine delivery. Expert Opinion on Drug Delivery 3:5, pages 557-561.
Read now
Read now
Thomas H Casswall & Björn Fischler. (2005) Vaccination of the immunocompromised child. Expert Review of Vaccines 4:5, pages 725-738.
Read now
Read now
Articles from other publishers (90)
Ryan S. Thwaites, Ashley S. S. Uruchurtu, Victor Augusti Negri, Megan E. Cole, Nehmat Singh, Nelisa Poshai, David Jackson, Katja Hoschler, Tina Baker, Ian C. Scott, Xavier Romero Ros, Emma Suzanne Cohen, Maria Zambon, Katrina M. Pollock, Trevor T. Hansel & Peter J. M. Openshaw. (2023) Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine. Nature Communications 14:1.
Crossref
Crossref
Eleni Vatzia, Katherine Feest, Adam McNee, Tanuja Manjegowda, B. Veronica Carr, Basudev Paudyal, Tiphany Chrun, Emmanuel A. Maze, Amy Mccarron, Susan Morris, Helen E. Everett, Ronan MacLoughlin, Francisco J. Salguero, Teresa Lambe, Sarah C. Gilbert & Elma Tchilian. (2023) Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs. npj Vaccines 8:1.
Crossref
Crossref
Yang Ge, Fengyuan Sun, Bo Zhao, Fanyang Kong, Zhaoshen Li & Xiangyu Kong. (2023) Bacteria derived extracellular vesicles in the pathogenesis and treatment of gastrointestinal tumours. Frontiers in Oncology 12.
Crossref
Crossref
Mariah Hassert & John T. Harty. (2022) Tissue resident memory T cells- A new benchmark for the induction of vaccine-induced mucosal immunity. Frontiers in Immunology 13.
Crossref
Crossref
Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels & Isabel Leroux-Roels. (2022) The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Frontiers in Immunology 13.
Crossref
Crossref
Sanchita Kar, Popy Devnath, Talha B. Emran, Trina E. Tallei, Saikat Mitra & Kuldeep Dhama. (2022) Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges. Immunity, Inflammation and Disease 10:4.
Crossref
Crossref
Geoffrey J Gorse, Susan M Rattigan, Alexander Kirpich, Michael S Simberkoff, Mary T Bessesen, Cynthia Gibert, Ann-Christine Nyquist, Connie Savor Price, Charlotte A Gaydos, Lewis J RadonovichJrJr, Trish M Perl, Maria C Rodriguez-Barradas & Derek A T Cummings. (2022) Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel. The Journal of Infectious Diseases 225:5, pages 891-902.
Crossref
Crossref
Geoffrey J. Gorse, Stephen Grimes, Helen Buck, Hussain Mulla, Peter White, Heather Hill, Jeanine May, Sharon E. Frey & Peter Blackburn. (2022) A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system. Vaccine 40:9, pages 1271-1281.
Crossref
Crossref
Yun‐Hee Kim, Kee‐Jong Hong, Hun Kim & Jae‐Hwan Nam. (2021) Influenza vaccines: Past, present, and future. Reviews in Medical Virology 32:1.
Crossref
Crossref
Saborni Chakraborty, Vamsee Mallajosyula, Cristina M. Tato, Gene S. Tan & Taia T. Wang. (2021) SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?. Advanced Drug Delivery Reviews 172, pages 314-338.
Crossref
Crossref
Yun-Hee Kim, Yoo-Jin Bang, Hyo-Jung Park, Hae Li Ko, Sang-In Park, Kyung-Ah Hwang, Hun Kim & Jae-Hwan Nam. (2020) Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection. Vaccine 38:39, pages 6141-6152.
Crossref
Crossref
Tong Wang, Fanhua Wei & Jinhua Liu. (2020) Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses. Viruses 12:8, pages 862.
Crossref
Crossref
Barbara Holzer, Sophie B. Morgan, Veronica Martini, Rajni Sharma, Becky Clark, Christopher Chiu, Francisco J. Salguero & Elma Tchilian. (2019) Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs. Frontiers in Immunology 10.
Crossref
Crossref
Someshwar Komati, Suryakanta SwainMuddana Eswara Bhanoji RaoBikash Ranjan JenaVishali Dasi. (2019) Mucoadhesive Multiparticulate Drug Delivery Systems: An ExtensiveReview of Patents. Advanced Pharmaceutical Bulletin 9:4, pages 521-538.
Crossref
Crossref
Laura Rodriguez, Pilar Blanco-Lobo, Emma C. Reilly, Tatsuya Maehigashi, Aitor Nogales, Andrew Smith, David J. Topham, Stephen Dewhurst, Baek Kim & Luis Martínez-Sobrido. (2019) Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines. Viruses 11:10, pages 928.
Crossref
Crossref
Yao Sun, Zhenwei Shen, Chun Zhang, Yanming Yi, Kunying Zhu, Fei Xu & Wei Kong. (2019) Development of a Stable Liquid Formulation for Live Attenuated Influenza Vaccine. Journal of Pharmaceutical Sciences 108:7, pages 2315-2322.
Crossref
Crossref
Wen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, Alicia Solórzano, Francesco Berlanda-Scorza, Adolfo García-Sastre, Peter Palese, Florian Krammer & Randy A. Albrecht. (2019) Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Frontiers in Immunology 10.
Crossref
Crossref
Jaspreet Singh Kochhar, Justin J. Y. Tan, Yee Chin Kwang & Lifeng KangJaspreet Singh Kochhar, Justin J. Y. Tan, Yee Chin Kwang & Lifeng Kang. 2019. Microneedles for Transdermal Drug Delivery. Microneedles for Transdermal Drug Delivery
95
144
.
Rie Nakajima, Medalyn Supnet, Algis Jasinskas, Aarti Jain, Omid Taghavian, Joshua Obiero, Donald K. Milton, Wilbur H. Chen, Michael Grantham, Richard Webby, Florian Krammer, Darrick Carter, Philip L. Felgner & D. Huw Davies. (2018) Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies. mSphere 3:6.
Crossref
Crossref
Annette Fox, Kylie M. Quinn & Kanta Subbarao. (2018) Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine. Drugs 78:13, pages 1297-1308.
Crossref
Crossref
Katja Höschler, Jo Southern, Catherine Thompson, Fiona Warburton, Nick J. Andrews, Elizabeth Miller & Maria Zambon. (2018) Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09). Vaccine 36:21, pages 3034-3040.
Crossref
Crossref
Kuang Tan, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2018) Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants. Frontiers in Microbiology 9.
Crossref
Crossref
Clementine S. Fraser, Akhilesh Jha & Peter J.M. Openshaw. (2017) Vaccines in the Prevention of Viral Pneumonia. Clinics in Chest Medicine 38:1, pages 155-169.
Crossref
Crossref
Eita Sasaki, Madoka Kuramitsu, Haruka Momose, Kouji Kobiyama, Taiki Aoshi, Hiroshi Yamada, Ken J. Ishii, Takuo Mizukami & Isao Hamaguchi. (2017) A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests. Vaccine 35:5, pages 821-830.
Crossref
Crossref
Diane L. Bolton, Kaimei Song, Georgia D. Tomaras, Srinivas Rao & Mario Roederer. (2017) Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques. Vaccine 35:4, pages 639-646.
Crossref
Crossref
Kristien Van Reeth, Amy L. Vincent & Kelly M. Lager. 2016. Animal Influenza. Animal Influenza
480
501
.
Jan Spitaels, Kenny Roose & Xavier Saelens. (2016) Influenza and Memory T Cells: How to Awake the Force. Vaccines 4:4, pages 33.
Crossref
Crossref
Jessica A. White, Marcus Estrada, E. Alexander Flood, Kutub Mahmood, Rajeev Dhere & Dexiang Chen. (2016) Development of a stable liquid formulation of live attenuated influenza vaccine. Vaccine 34:32, pages 3676-3683.
Crossref
Crossref
Sangchul Yoon, Eun-Do Kim, Min-Suk Song, Soo Jung Han, Tae Kwann Park, Kyoung Sub Choi, Young-Ki Choi & Kyoung Yul Seo. (2016) Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets. PLOS ONE 11:6, pages e0157634.
Crossref
Crossref
J. Rahn, D. Hoffmann, T.C. Harder & M. Beer. (2015) Vaccines against influenza A viruses in poultry and swine: Status and future developments. Vaccine 33:21, pages 2414-2424.
Crossref
Crossref
Saranya Sridhar, Karl Brokstad & Rebecca Cox. (2015) Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines. Vaccines 3:2, pages 373-389.
Crossref
Crossref
Mariana Baz, Myeisha Paskel, Yumiko Matsuoka, James Zengel, Xing Cheng, John J. Treanor, Hong Jin & Kanta Subbarao. (2015) A Live Attenuated Equine H3N8 Influenza Vaccine Is Highly Immunogenic and Efficacious in Mice and Ferrets. Journal of Virology 89:3, pages 1652-1659.
Crossref
Crossref
C. McEntee, E.C. Lavelle & D.T. O’Hagan. 2015. Mucosal Immunology. Mucosal Immunology
1211
1231
.
Aayam Lamichhane, Tatsuhiko Azegami & Hiroshi Kiyono. (2014) The mucosal immune system for vaccine development. Vaccine 32:49, pages 6711-6723.
Crossref
Crossref
Agnieszka Rynda-Apple, Dustin P Patterson & Trevor Douglas. (2014) Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung. Nanomedicine 9:12, pages 1857-1868.
Crossref
Crossref
Irina Isakova-Sivak, Li-Mei Chen, Melissa Bourgeois, Yumiko Matsuoka, J. Theo M. Voeten, Jacco G. M. Heldens, Han van den Bosch, Alexander Klimov, Larisa Rudenko, Nancy J. Cox & Ruben O. Donis. (2014) Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model. Clinical and Vaccine Immunology 21:5, pages 722-731.
Crossref
Crossref
Yo Han Jang, Eun-Young Lee, Young Ho Byun, Eun-Ju Jung, Yoon Jae Lee, Yun Ha Lee, Kwang-Hee Lee, Jinhee Lee & Baik Lin Seong. (2014) Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Vaccine 32:5, pages 535-543.
Crossref
Crossref
Tomonori Nochi, Yoshikazu Yuki, Kazunari Akiyoshi & Hiroshi Kiyono. 2014. Mucosal Delivery of Biopharmaceuticals. Mucosal Delivery of Biopharmaceuticals
325
332
.
Ruben O. Donis. 2014. Influenza Pathogenesis and Control - Volume I. Influenza Pathogenesis and Control - Volume I
403
440
.
Yo Han Jang, Young Ho Byun, Kwang-Hee Lee, Eun-Sook Park, Yun Ha Lee, Yoon-Jae Lee, Jinhee Lee, Kyun-Hwan Kim & Baik Lin Seong. (2013) Host Defense Mechanism-Based Rational Design of Live Vaccine. PLoS ONE 8:10, pages e75043.
Crossref
Crossref
S. Kommareddy, B.C. Baudner, A. Bonificio, S. Gallorini, G. Palladino, A.S. Determan, D.M. Dohmeier, K.D. Kroells, J.R. Sternjohn, M. Singh, P.R. Dormitzer, K.J. Hansen & D.T. O’Hagan. (2013) Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 31:34, pages 3435-3441.
Crossref
Crossref
Mariana Manrique, Pamela A. Kozlowski, Antonio Cobo-Molinos, Shainn-Wei Wang, Robert L. Wilson, David C. Montefiori, Angela Carville & Anna Aldovini. (2013) Immunogenicity of a Vaccine Regimen Composed of Simian Immunodeficiency Virus DNA, rMVA, and Viral Particles Administered to Female Rhesus Macaques via Four Different Mucosal Routes. Journal of Virology 87:8, pages 4738-4750.
Crossref
Crossref
Benjaluck Phonrat, Punnee Pitisuttithum, Supat Chamnanchanunt, Pilaipan Puthavathana, Nathamon Ngaosuwankul, Suda Louisirirotchanakul, Jittima Dhitavat, Sit Thirapakpoomanunt, Vichai Chokevivat & Suwit Wibulpolprasert. (2013) Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais. Vaccine 31:11, pages 1503-1509.
Crossref
Crossref
Yo Han Jang, Young Ho Byun, Dong-Hun Lee, Kwang-Hee Lee, Yoon Jae Lee, Yun Ha Lee, Jae-Keun Park, Chang-Seon Song & Baik Lin Seong. (2013) Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets. Vaccine 31:9, pages 1320-1327.
Crossref
Crossref
Kawsar R. Talaat, Ruth A. Karron, Philana H. Liang, Bridget A. McMahon, Catherine J. Luke, Bhagvanji Thumar, Grace L. Chen, Ji-Young Min, Elaine W. Lamirande, Hong Jin, Kathy L. Coelingh, George W. Kemble & Kanta Subbarao. (2013) An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza and Other Respiratory Viruses 7:1, pages 66-73.
Crossref
Crossref
Maria Ines Barría, Jose Luis Garrido, Cheryl Stein, Erica Scher, Yongchao Ge, Stephanie M. Engel, Thomas A. Kraus, David Banach & Thomas M. Moran. (2013) Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults. The Journal of Infectious Diseases 207:1, pages 115-124.
Crossref
Crossref
Jiri Beran & Jeff Goad. 2013. Travel Medicine. Travel Medicine
87
100
.
Heng Liu, Harshad P. Patil, Jacqueline de Vries-Idema, Jan Wilschut & Anke Huckriede. (2012) Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100. PLoS ONE 7:12, pages e52135.
Crossref
Crossref
Dan Zheng, Yinglei Yi & Ze Chen. (2012) Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza. Viruses 4:12, pages 3589-3605.
Crossref
Crossref
Natalia A. Ilyushina, Mine R. Ikizler, Yoshihiro Kawaoka, Larisa G. Rudenko, John J. Treanor, Kanta Subbarao & Peter F. Wright. (2012) Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway Epithelium. Journal of Virology 86:21, pages 11725-11734.
Crossref
Crossref
Ana Vujanic, Philip Sutton, Kenneth J. Snibson, Hung-Hsun Yen & Jean-Pierre Y. Scheerlinck. (2012) Mucosal vaccination: Lung versus nose. Veterinary Immunology and Immunopathology 148:1-2, pages 172-177.
Crossref
Crossref
Gourapura J. Renukaradhya, Varun Dwivedi, Cordelia Manickam, Basavaraj Binjawadagi & David Benfield. (2012) Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective. Animal Health Research Reviews 13:1, pages 21-37.
Crossref
Crossref
Laura E. Richert, Amy E. Servid, Ann L. Harmsen, Agnieszka Rynda-Apple, Soo Han, James A. Wiley, Trevor Douglas & Allen G. Harmsen. (2012) A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine 30:24, pages 3653-3665.
Crossref
Crossref
Jennifer Humberd Smith, Mark Papania, Darin Knaus, Paula Brooks, Debra L. Haas, Raydel Mair, James Barry, S. Mark Tompkins & Ralph A. Tripp. (2012) Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose. Vaccine 30:19, pages 3026-3033.
Crossref
Crossref
Min-Shi Lee & Alan Yung-Chih Hu. (2012) A cell-based backup to speed up pandemic influenza vaccine production. Trends in Microbiology 20:3, pages 103-105.
Crossref
Crossref
Seol Hee Hong, Young-Ho Byun, Chung Truong Nguyen, Soo Young Kim, Baik Lin Seong, Songyong Park, Gyu-Jin Woo, Yeup Yoon, Jeong Tae Koh, Kohtaro Fujihashi, Joon Haeng Rhee & Shee Eun Lee. (2012) Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine 30:2, pages 466-474.
Crossref
Crossref
Allen Chen, Swan Li Poh, Christian Dietzsch, Elisabeth Roethl, Mylene L Yan & Say Kong Ng. (2011) Serum-free microcarrier based production of replication deficient Influenza vaccine candidate virus lacking NS1 using Vero cells. BMC Biotechnology 11:1.
Crossref
Crossref
K. M. Gustin, T. R. Maines, J. A. Belser, N. van Hoeven, X. Lu, L. Dong, I. Isakova-Sivak, L.-M. Chen, J. T. M. Voeten, J. G. M. Heldens, H. van den Bosch, N. J. Cox, T. M. Tumpey, A. I. Klimov, L. Rudenko, R. O. Donis & J. M. Katz. (2011) Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets. Journal of Infectious Diseases 204:10, pages 1491-1499.
Crossref
Crossref
Mark S. Riddle, Robert W. Kaminski, Carlos Williams, Chad Porter, Shahida Baqar, Alexis Kordis, Theron Gilliland, Joyce Lapa, Melissa Coughlin, Chris Soltis, Erica Jones, Jackie Saunders, Paul B. Keiser, Ryan T. Ranallo, Robert Gormley, Michael Nelson, K. Ross Turbyfill, David Tribble & Edwin V. Oaks. (2011) Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine 29:40, pages 7009-7019.
Crossref
Crossref
Shu Meng, Zhonghua Liu, Lili Xu, Li Li, Shan Mei, Linlin Bao, Wei Deng, Lina Li, Rongyue Lei, Liangzhi Xie, Chuan Qin & Linqi Zhang. (2011) Intranasal Immunization with Recombinant HA and Mast Cell Activator C48/80 Elicits Protective Immunity against 2009 Pandemic H1N1 Influenza in Mice. PLoS ONE 6:5, pages e19863.
Crossref
Crossref
Grace L. Chen, Ji-Young Min, Elaine W. Lamirande, Celia Santos, Hong Jin, George Kemble & Kanta Subbarao. (2011) Comparison of a Live Attenuated 2009 H1N1 Vaccine with Seasonal Influenza Vaccines against 2009 Pandemic H1N1 Virus Infection in Mice and Ferrets. The Journal of Infectious Diseases 203:7, pages 930-936.
Crossref
Crossref
Seyyed Mahmoud Ebrahimi & Majid Tebianian. (2010) Influenza A viruses: why focusing on M2e-based universal vaccines. Virus Genes 42:1, pages 1-8.
Crossref
Crossref
Raburn M. Mallory, Elissa Malkin, Christopher S. Ambrose, Terramika Bellamy, Li Shi, Tingting Yi, Taff Jones, George Kemble & Filip Dubovsky. (2010) Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials. PLoS ONE 5:10, pages e13755.
Crossref
Crossref
Jean-Pierre Amorij, Wouter LJ Hinrichs, Henderik W Frijlink, Jan C Wilschut & Anke Huckriede. (2010) Needle-free influenza vaccination. The Lancet Infectious Diseases 10:10, pages 699-711.
Crossref
Crossref
Tomonori Nochi, Yoshikazu Yuki, Haruko Takahashi, Shin-ichi Sawada, Mio Mejima, Tomoko Kohda, Norihiro Harada, Il Gyu Kong, Ayuko Sato, Nobuhiro Kataoka, Daisuke Tokuhara, Shiho Kurokawa, Yuko Takahashi, Hideo Tsukada, Shunji Kozaki, Kazunari Akiyoshi & Hiroshi Kiyono. (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nature Materials 9:7, pages 572-578.
Crossref
Crossref
Althaf I. Hussain, Melissa Cordeiro, Elizabeth Sevilla & Jonathan Liu. (2010) Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells. Vaccine 28:22, pages 3848-3855.
Crossref
Crossref
Eun-Young Lee, Kwang-Hee Lee, Eun-Ju Jung, Yo Han Jang, Sang-Uk Seo, Hyun-Ah Kim & Baik Lin Seong. (2010) Genotyping and screening of reassortant live-attenuated influenza B vaccine strain. Journal of Virological Methods 165:2, pages 133-138.
Crossref
Crossref
Grace L. Chen, Elaine W. Lamirande, Hong Jin, George Kemble & Kanta Subbarao. (2010) Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398:1, pages 109-114.
Crossref
Crossref
Jeffrey S. Brown, Kristen M. Moore, M Miles Braun, Najat Ziyadeh, K Arnold Chan, Grace M. Lee, Martin Kulldorff, Alexander M. Walker & Richard Platt. (2009) Active Influenza Vaccine Safety Surveillance. Medical Care 47:12, pages 1251-1257.
Crossref
Crossref
Kawsar R. Talaat, Ruth A. Karron, Karen A. Callahan, Catherine J. Luke, Susan C. DiLorenzo, Grace L. Chen, Elaine W. Lamirande, Hong Jin, Kathy L. Coelingh, Brian R. Murphy, George Kemble & Kanta Subbarao. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:28, pages 3744-3753.
Crossref
Crossref
Humberto Bracco Neto, Calil K. Farhat, Miguel Wenceslao Tregnaghi, Shabir A. Madhi, Ahmad Razmpour, Giuseppe Palladino, Margaret G. Small, William C. Gruber & Bruce D. Forrest. (2009) Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive Children. Pediatric Infectious Disease Journal 28:5, pages 365-371.
Crossref
Crossref
Fengmin Zhou, Amanda Goodsell, Yasushi Uematsu & Michael Vajdy. (2009) Prolonged Protection against Intranasal Challenge with Influenza Virus following Systemic Immunization or Combinations of Mucosal and Systemic Immunizations with a Heat-Labile Toxin Mutant. Clinical and Vaccine Immunology 16:4, pages 471-478.
Crossref
Crossref
Zhongying Chen, Celia Santos, Amy Aspelund, Laura Gillim-Ross, Hong Jin, George Kemble & Kanta Subbarao. (2009) Evaluation of Live Attenuated Influenza A Virus H6 Vaccines in Mice and Ferrets. Journal of Virology 83:1, pages 65-72.
Crossref
Crossref
Herman J. Bueving & Johannes C. van der Wouden. 2010. Allergy Frontiers: Therapy and Prevention. Allergy Frontiers: Therapy and Prevention
611
619
.
Ralph A. Tripp & S. Mark Tompkins. 2009. Vaccines for Pandemic Influenza. Vaccines for Pandemic Influenza
397
412
.
Daniela Damjanovic, Xizhong Zhang, Jingyu Mu, Maria Fe Medina & Zhou Xing. (2008) Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Genetic Vaccines and Therapy 6:1.
Crossref
Crossref
Jun Kunisawa, Tomonori Nochi & Hiroshi Kiyono. (2008) Immunological commonalities and distinctions between airway and digestive immunity. Trends in Immunology 29:11, pages 505-513.
Crossref
Crossref
Zhongying Chen, Amy Aspelund, George Kemble & Hong Jin. (2008) Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist® vaccines. Virology 380:2, pages 354-362.
Crossref
Crossref
J-P. Amorij, A. Huckriede, J. Wilschut, H. W. Frijlink & W. L. J. Hinrichs. (2008) Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities. Pharmaceutical Research 25:6, pages 1256-1273.
Crossref
Crossref
Antoine Minne, François Huaux, Joanna Jaworska, Ro-Dug Rha, Eckard Hamelmann & Rita Vanbever. (2008) Safety evaluation of pulmonary influenza vaccination in healthy and “asthmatic” mice. Vaccine 26:19, pages 2360-2368.
Crossref
Crossref
Stanley A. Plotkin. (2008) Nouvelles stratégies de la vaccination. Bulletin de l'Académie Nationale de Médecine 192:3, pages 511-519.
Crossref
Crossref
David O. Freedman, Abinash Virk & Elaine C. Jong. 2008. Travel Medicine. Travel Medicine
85
120
.
H. J. Bueving & J. C. van der Wouden. (2007) Moeten kinderen met astma worden ingeënt tegen griep?. Bijblijven 23:10, pages 43-49.
Crossref
Crossref
Pedro A. Piedra, Manjusha J. Gaglani, Claudia A. Kozinetz, Gayla B. Herschler, Charles Fewlass, Dianne Harvey, Nadine Zimmerman & W. Paul Glezen. (2007) Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003–2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children. Pediatrics 120:3, pages e553-e564.
Crossref
Crossref
Robert B. Belshe, Kathryn M. Edwards, Timo Vesikari, Steven V. Black, Robert E. Walker, Micki Hultquist, George Kemble & Edward M. Connor. (2007) Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children. New England Journal of Medicine 356:7, pages 685-696.
Crossref
Crossref
Jeffrey B Ulmer, Ulrich Valley & Rino Rappuoli. (2006) Vaccine manufacturing: challenges and solutions. Nature Biotechnology 24:11, pages 1377-1383.
Crossref
Crossref
Douglas M. Fleming, Pietro Crovari, Ulrich Wahn, Timo Klemola, Yechiel Schlesinger, Alexangros Langussis, Knut ??ymar, Maria Luz Garcia, Alain Krygier, Herculano Costa, Ulrich Heininger, Jean-Louis Pregaldien, Sheau-Mei Cheng, Jonathan Skinner, Ahmad Razmpour, Melanie Saville, William C. Gruber & Bruce Forrest. (2006) Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma. The Pediatric Infectious Disease Journal 25:10, pages 860-869.
Crossref
Crossref
Sabine Sereinig, Marina Stukova, Natalia Zabolotnyh, Boris Ferko, Christian Kittel, Julia Romanova, Tatiana Vinogradova, Hermann Katinger, Oleg Kiselev & Andrej Egorov. (2006)
Influenza Virus NS Vectors Expressing the
Mycobacterium tuberculosis
ESAT-6 Protein Induce CD4
+
Th1 Immune Response and Protect Animals against Tuberculosis Challenge
. Clinical and Vaccine Immunology 13:8, pages 898-904.
Crossref
Crossref
M.A. Stukova, S. Sereinig, N.V. Zabolotnyh, B. Ferko, C. Kittel, J. Romanova, T.I. Vinogradova, H. Katinger, O.I. Kiselev & A. Egorov. (2006) Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis 86:3-4, pages 236-246.
Crossref
Crossref
Jan Holmgren & Cecil Czerkinsky. (2005) Mucosal immunity and vaccines. Nature Medicine 11:S4, pages S45-S53.
Crossref
Crossref